Peter Boström

Palliative MRI-guided transurethral ultrasound ablation for symptomatic locally advanced prostate cancer (2020)

Scandinavian Journal of Urology

Mikael Anttinen, Pietari Mäkelä, Pertti Nurminen, Eemil Yli-Pietilä, Visa Suomi, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. Boström

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Impact of biparametric prebiopsy prostate magnetic resonance imaging on the diagnostics of clinically significant prostate cancer in biopsy naïve men (2020)

Scandinavian Journal of Urology

Knaapila J, Autio V, Jambor I, Ettala O, Verho J, Kiviniemi A, Taimen P, Perez IM, Aronen HJ, Syvänen KT, Boström PJ

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques (2020)

Journal of Magnetic Resonance Imaging

Ileana Montoya Perez, Ivan Jambor, Tapio Pahikkala, Antti Airola, Harri Merisaari, Jani Saunavaara, Saeid Alinezhad, Riina-Minna Väänänen, Terhi Tallgrén, Janne Verho, Aida Kiviniemi, Otto Ettala, Juha Knaapila, Kari T. Syvänen, Markku Kallajoki, Paula Vainio, Hannu J. Aronen, Kim Pettersson, Peter J. Boström, Pekka Taimen

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor (2020)

European Urology Oncology

Gregory J Nason, Michael A S Jewett, Peter J Boström, Hanan Goldberg, Aaron R Hansen, Philippe L Bedard, Jeremy Sturgeon, Padraig Warde, Peter Chung, Lynn Anson-Cartwright, Joan Sweet, Eshetu G Atenafu, Martin O'Malley, Robert J Hamilton

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4: Can Patient-derived Cancer Models Change the Costliest Cancer Type? (2020)

European Urology

Kimmo Kettunen, Peter Boström, Pekka Taimen

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Prediction of prostate cancer aggressiveness using 18 F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI (2020)

Scientific Reports

Movahedi P, Merisaari H, Perez IM, Taimen P, Kemppainen J, Kuisma A, Eskola O, Teuho J, Saunavaara J, Pesola M, Kähkönen E, Ettala O, Liimatainen T, Pahikkala T, Boström P, Aronen H, Minn H, Jambor I

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Re: Antonio C. Westphalen, Charles E. McCulloch, Jordan M. Anaokar, et al. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology 2020;296:76–84: Can the Positive Predictive Value of Prostate MRI in Correlation with Biopsy Findings be Interpreted Without Diving into Details? (2020)

European Urology Oncology

Ivan Jambor, Ugo G Falagario, Alberto Martini, David Eldred-Evans, Hashim U Ahmed, Peter J Boström; on behalf of the PROMOD Study Group

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation (2020)

BMC Urology

Seikkula H, Boström PJ, Seppä K, Pitkäniemi J, Malila N, Kaipia A

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (2020)

New England Journal of Medicine

Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R, Akaza H, Bossi A, van Veenhuyzen DF, Selby B, Fan X, Kang V, Walling J, Tombal B; for the HERO Study Investigators

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Vasectomy and the risk of prostate cancer in a Finnish nationwide population-based cohort (2020)

Cancer Epidemiology

Seikkula H, Kaipia A, Hirvonen E, Rantanen M, Pitkäniemi J, Malila N, Boström PJ

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Links

Publications

Sort by:

Palliative MRI-guided transurethral ultrasound ablation for symptomatic locally advanced prostate cancer (2020)

Impact of biparametric prebiopsy prostate magnetic resonance imaging on the diagnostics of clinically significant prostate cancer in biopsy naïve men (2020)

Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques (2020)

Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor (2020)

Prediction of prostate cancer aggressiveness using 18 F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI (2020)

Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation (2020)

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (2020)

Vasectomy and the risk of prostate cancer in a Finnish nationwide population-based cohort (2020)